Clinical Trial Update: Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial completed to evaluate the pharmacokinetics, pharmacodynamics and safety of Tiprogrel in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Stroke

Drugs mentioned

• Tiprogrel (Tiprogrel)

Snippet

Sponsor: Tianjin Institute of Pharmaceutical Research Co., Ltd | Conditions: Acute Coronary Syndrome, Ischemic Stroke | Phase 1 | Status: COMPLETED